Femasys Stock Alpha and Beta Analysis

FEMY Stock  USD 1.59  0.21  15.22%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Femasys. It also helps investors analyze the systematic and unsystematic risks associated with investing in Femasys over a specified time horizon. Remember, high Femasys' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Femasys' market risk premium analysis include:
Beta
0.77
Alpha
0.6
Risk
4.21
Sharpe Ratio
0.23
Expected Return
0.97
Please note that although Femasys alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Femasys did 0.60  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Femasys stock's relative risk over its benchmark. Femasys has a beta of 0.77  . As returns on the market increase, Femasys' returns are expected to increase less than the market. However, during the bear market, the loss of holding Femasys is expected to be smaller as well. At this time, Femasys' Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 1.13 in 2025, despite the fact that Enterprise Value is likely to grow to (16.9 K).

Enterprise Value

(16,855.53)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Femasys Backtesting, Femasys Valuation, Femasys Correlation, Femasys Hype Analysis, Femasys Volatility, Femasys History and analyze Femasys Performance.
For more information on how to buy Femasys Stock please use our How to Invest in Femasys guide.

Femasys Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Femasys market risk premium is the additional return an investor will receive from holding Femasys long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Femasys. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Femasys' performance over market.
α0.60   β0.77

Femasys expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Femasys' Buy-and-hold return. Our buy-and-hold chart shows how Femasys performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Femasys Market Price Analysis

Market price analysis indicators help investors to evaluate how Femasys stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Femasys shares will generate the highest return on investment. By understating and applying Femasys stock market price indicators, traders can identify Femasys position entry and exit signals to maximize returns.

Femasys Return and Market Media

The median price of Femasys for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 is 1.11 with a coefficient of variation of 8.94. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 1.12, and mean deviation of 0.07. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Aljian Capital Management LLC Makes New 27,000 Investment in Femasys Inc.
11/19/2024
2
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed Infertility Treatment
11/26/2024
3
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility ...
12/03/2024
4
Symbol Lookup
01/16/2025
5
Acquisition by Dov Elefant of 72045 shares of Femasys at 1.05 subject to Rule 16b-3
01/28/2025
6
Acquisition by Lee-sepsick Kathy of 59849 shares of Femasys at 1.17 subject to Rule 16b-3
01/29/2025
7
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications ...
01/30/2025
8
Femasys Announces UK Regulatory Approvals for FemaSeed for Fema
02/11/2025
9
Femasys Announces UK Regulatory Approvals for FemaSeed for Female Infertility Treatment and Two Diagnostic Devices - Marketscreener.com
02/12/2025

About Femasys Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Femasys or other stocks. Alpha measures the amount that position in Femasys has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 2025 (projected)
Payables Turnover0.870.330.30.47
Days Of Inventory On Hand360.69640.67576.6605.43

Femasys Upcoming Company Events

As portrayed in its financial statements, the presentation of Femasys' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Femasys' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Femasys' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Femasys. Please utilize our Beneish M Score to check the likelihood of Femasys' management manipulating its earnings.
4th of April 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Femasys

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Femasys Stock Analysis

When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.